EMAIL THIS PAGE TO A FRIEND

The Journal of molecular diagnostics : JMD

Mutations in the Kinase Domain of the HER2/ERBB2 Gene Identified in a Wide Variety of Human Cancers.


PMID 26320869

Abstract

The HER2 (official name ERBB2) gene encodes a membrane receptor in the epidermal growth factor receptor family amplified and overexpressed in adenocarcinoma. Activating mutations also occur in several cancers. We report mutation analyses of the HER2 kinase domain in 7497 histologically diverse cancers. Forty-five genes, including the kinase domain of HER2 with HER2 IHC and dual in situ hybridization, were analyzed in tumors from 7497 patients with cancer, including 850 breast, 770 colorectal, 910 non-small cell lung, 823 uterine or cervical, 1372 ovarian, and 297 pancreatic cancers, as well as 323 melanomas and 2152 other solid tumors. Sixty-nine HER2 kinase domain mutations were identified in tumors from 68 patients (approximately 1% of all cases, ranging from absent in sarcomas to 4% in urothelial cancers), which included previously published activating mutations and 13 novel mutations. Fourteen cases with coexisting HER2 mutation and amplification and/or overexpression were identified. Fifty-two of 68 patients had additional mutations in other analyzed genes, whereas 16 patients (23%) had HER2 mutations identified as the sole driver mutation. HER2 mutations coexisted with HER2 gene amplification and overexpression and with mutations in other functionally important genes. HER2 mutations were identified as the only driver mutation in a significant proportion of solid cancers. Evaluation of anti-HER2 therapies in nonamplified, HER2-mutated cancers is warranted.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

SAB4300350
Anti-ERBB2 (Ab-1221/1222) antibody produced in rabbit, affinity isolated antibody
SAB4300351
Anti-ERBB2 (Ab-1248) antibody produced in rabbit, affinity isolated antibody
SAB4300349
Anti-ERBB2 (Ab-877) antibody produced in rabbit, affinity isolated antibody
GW22631 Anti-ERBB2 antibody produced in chicken, affinity isolated antibody, buffered aqueous solution
HPA001383
Anti-ERBB2 antibody produced in rabbit, Ab1, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution
SAB4500782
Anti-HER2 antibody produced in rabbit, affinity isolated antibody
SAB4500783
Anti-HER2 antibody produced in rabbit, affinity isolated antibody
SAB4500787
Anti-HER2 antibody produced in rabbit, affinity isolated antibody
SAB4500789
Anti-HER2 antibody produced in rabbit, affinity isolated antibody
SAB4500784
Anti-HER2, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4500785
Anti-HER2, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4500786
Anti-HER2, C-Terminal antibody produced in rabbit, affinity isolated antibody
SAB4500788
Anti-HER2, C-Terminal antibody produced in rabbit, affinity isolated antibody
A0781
Aphidicolin from Nigrospora sphaerica, ≥98% (HPLC), powder
C20H34O4
E2777 Monoclonal Anti-c-erbB-2 antibody produced in mouse, ~2 mg/mL, clone HER2-96, purified immunoglobulin, buffered aqueous solution
WH0002064M6
Monoclonal Anti-ERBB2 antibody produced in mouse, clone 4B8, purified immunoglobulin, buffered aqueous solution
SAB1403787
Monoclonal Anti-ERBB2 antibody produced in mouse, clone 3B1, purified immunoglobulin, buffered aqueous solution
AMAB90628
Monoclonal Anti-HER2 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL0269, purified immunoglobulin, buffered aqueous glycerol solution
AMAB90627
Monoclonal Anti-HER2 antibody produced in mouse, Prestige Antibodies® Powered by Atlas Antibodies, clone CL0268, purified immunoglobulin, buffered aqueous glycerol solution